Blood PressureSIMPLE-AOBPNCT06317168
SIMPLifying Elements of Standardized Automated Office Blood Pressure Measurements (Pilot Study)
A study testing Mean awake ambulatory BP measurements in people with Blood Pressure, run by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal at 1 site in Canada.
Trial summary
This study aims to assess whether removing single elements of the standardized office BP measurement procedure will affect the accuracy towards the mean awake ambulatory BP. Four arms are planned in a randomized order: 1) full standardized procedure, 2) standardized procedure but with cuff placed on a sleeve, 3)… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Blood Pressure
- What is being tested?
- Mean awake ambulatory BP measurements
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteCanada
- Study dates
- 9 May 2024to 5 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults ≥ 18 years old
Who cannot join
- Upper arm size outside of cuff range of selected devices (<22 cm or >42 cm)
- Permanent atrial fibrillation
- Known severe aortic stenosis
- Ongoing pregnancy
- Inability or unwillingness to provide consent
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to assess whether removing single elements of the standardized office BP measurement procedure will affect the accuracy towards the mean awake ambulatory BP. Four arms are planned in a randomized order: 1) full standardized procedure, 2) standardized procedure but with cuff placed on a sleeve, 3) standardized procedure but arm resting vertically, 4) standardized procedure but with non-validated device.
This is a pilot study to inform on the sample size required to perform adequately powered large scale studies.
Read the detailed description
Accurate and reliable blood pressure (BP) measurements are key for hypertension management. To this regard, all hypertension societies recommend using highly standardized automated oscillometric office BP measurements (AOBP) as a way to minimise measurement biases, enhance reproducibility and allow comparability. The standardized AOBP procedure emphasizes the need to measure BP in a controlled environment with optimal body positioning, the use of an appropriately sized cuff over a bare arm and a clinically validated oscillometric BP devices. It is also recommended to average >2 measurements at 30-60 seconds intervals after several minutes of seated rest alone in a quiet room. As such, important barriers exist to implement standardized AOBP in real-life settings, as this procedure requires time, space and patient mobility.
A 2017 meta-analysis evaluated the impact of several elements of oscillometric and auscultatory BP readings on systolic and diastolic BP levels. It showed that while most components of BP measurements appear to influence BP, the majority of included studies were of relatively low methodological quality (including unstandardized BP measurements, lack of randomisation, auscultatory method, absence or differences in rest periods, single readings, single cuff size) and almost none were compared with th gold-standard BP measurement, i.e average awake ambulatory BP measurements (ABPM). Since, two meta-analyses specifically assessing the effect of attendance during AOBP were published and showed conflicting results. While important components of AOBP (rest period and cuff size) were recently tested using a rigorous methodology, data is still missing for most elements.
Simplifying the AOBP procedure could result in improvements in acceptability and implementation. The need to perform this highly standardized procedure exerts pressure on patients, providers and administrative staff. Indeed, patients need to be properly seated alone in a quiet dedicated room in a chair with an arm rest that need to be adjustable to position the upper arm at heart level. This setup is seldom available apart in highly specialized hypertension clinics. Also, the arm must be bare, which can bring discomfort to patients with the requirement to remove their clothing or roll up the sleeves, which introduces another potential source of inaccuracy due to the tourniquet effect or the inability to completely uncover the upper arm. It can also introduce significant time delays in a clinical setting for less mobile patients. Furthermore, the BP device must be clinically validated for its accuracy. The lack of regulation and the ease of online purchase means many patients may be drawn to purchasing less expensive non-validated devices. While this problem may be more widespread in the home setting, not all office BP measuring devices are validated and recommended by Hypertension Canada.
The primary objective of the SIMPLE-AOBP study is to assess whether foregoing, or simplifying, specific elements of the AOBP procedure affects its accuracy towards the gold-standard mean awake ABPM. This study will employ a rigorous methodology (highly standardized measurements, identical settings and rest periods, randomization, blinded assessment of outcomes, averaged multiple BP measurements) to minimise measurement biases not related to the studies elements. The study will focus on three easily addressable elements: 1) the need the measure BP on a bare arm, 2) the requirement of supporting the arm at heart level and 3) the need to use a validated BP device. This trial will provide important pilot data to help design adequately powered large scale studies.
- Conditions
- Blood Pressure
- Being tested
- Mean awake ambulatory BP measurements
- Keywords
- blood pressure measurements
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mean awake ambulatory BP measurementsDiagnostic test
Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.
| Study group | Role | What they receive |
|---|---|---|
| Standardized automated office BP measurements | Active comparator | BP measured using a highly standardized procedure using a validated office-grade device on a bare arm supported at heart level. Receives: Diagnostic Test: Mean awake ambulatory BP measurements |
| Sleeved arm | Active comparator | BP measured using a highly standardized procedure using a validated office-grade device over a standardized sleeve with the arm supported at heart level. Receives: Diagnostic Test: Mean awake ambulatory BP measurements |
| Arm not supported | Active comparator | BP measured using a highly standardized procedure using a validated office-grade device on a bare arm resting vertically. Receives: Diagnostic Test: Mean awake ambulatory BP measurements |
| Non-validated device | Active comparator | BP measured using a highly standardized procedure using a non-validated home device on a bare arm supported at heart level. Receives: Diagnostic Test: Mean awake ambulatory BP measurements |
What is being measured
The primary outcome is the main question the study is designed to answer.
Difference with mean awake ambulatory systolic BP
Difference between systolic BP measured in each study arm (average of 3 measurements) with the mean awake ambulatory systolic BP
Measured: at enrollment (time 0)
Secondary outcomes (1)
Difference with mean awake ambulatory diastolic BP
Difference between diastolic BP measured in each study arm (average of 3 measurements) with the mean awake ambulatory diastolic BP
Measured: at enrollment (time 0)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2024
- Study start9 May 2024
- Primary completion5 Sep 2024
- Study completion5 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood PressureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06317168
- Sponsor's protocol ID
- SIMPLE-AOBP
- Acronym
- SIMPLE-AOBP
- Status last verified
- Feb 2025
- First submitted
- 11 Mar 2024
- Last updated
- 12 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Data will not be shared (pilot study)
Study at a glance
From the registry record, last updated by the sponsor on 12 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- SIMPLifying Elements of Standardized Automated Office Blood Pressure Measurements (Pilot Study)
- ClinicalTrials.gov ID
- NCT06317168
- Acronym / sponsor ID
- SIMPLE-AOBP / SIMPLE-AOBP
- Conditions
- Blood Pressure
- Keywords
- blood pressure measurements
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de MontrealUniversity, hospital or other
- Study start
- 9 May 2024 (actual)
- Primary completion
- 5 Sep 2024 (actual)
- Study completion
- 5 Sep 2024 (actual)
- First posted
- 19 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to assess whether removing single elements of the standardized office BP measurement procedure will affect the accuracy towards the mean awake ambulatory BP. Four arms are planned in a randomized order: 1) full standardized procedure, 2) standardized procedure but with cuff placed on a sleeve, 3) standardized procedure but arm resting vertically, 4) standardized procedure but with non-validated device.
This is a pilot study to inform on the sample size required to perform adequately powered large scale studies.
Detailed description
Accurate and reliable blood pressure (BP) measurements are key for hypertension management. To this regard, all hypertension societies recommend using highly standardized automated oscillometric office BP measurements (AOBP) as a way to minimise measurement biases, enhance reproducibility and allow comparability. The standardized AOBP procedure emphasizes the need to measure BP in a controlled environment with optimal body positioning, the use of an appropriately sized cuff over a bare arm and a clinically validated oscillometric BP devices. It is also recommended to average >2 measurements at 30-60 seconds intervals after several minutes of seated rest alone in a quiet room. As such, important barriers exist to implement standardized AOBP in real-life settings, as this procedure requires time, space and patient mobility.
A 2017 meta-analysis evaluated the impact of several elements of oscillometric and auscultatory BP readings on systolic and diastolic BP levels. It showed that while most components of BP measurements appear to influence BP, the majority of included studies were of relatively low methodological quality (including unstandardized BP measurements, lack of randomisation, auscultatory method, absence or differences in rest periods, single readings, single cuff size) and almost none were compared with th gold-standard BP measurement, i.e average awake ambulatory BP measurements (ABPM). Since, two meta-analyses specifically assessing the effect of attendance during AOBP were published and showed conflicting results. While important components of AOBP (rest period and cuff size) were recently tested using a rigorous methodology, data is still missing for most elements.
Simplifying the AOBP procedure could result in improvements in acceptability and implementation. The need to perform this highly standardized procedure exerts pressure on patients, providers and administrative staff. Indeed, patients need to be properly seated alone in a quiet dedicated room in a chair with an arm rest that need to be adjustable to position the upper arm at heart level. This setup is seldom available apart in highly specialized hypertension clinics. Also, the arm must be bare, which can bring discomfort to patients with the requirement to remove their clothing or roll up the sleeves, which introduces another potential source of inaccuracy due to the tourniquet effect or the inability to completely uncover the upper arm. It can also introduce significant time delays in a clinical setting for less mobile patients. Furthermore, the BP device must be clinically validated for its accuracy. The lack of regulation and the ease of online purchase means many patients may be drawn to purchasing less expensive non-validated devices. While this problem may be more widespread in the home setting, not all office BP measuring devices are validated and recommended by Hypertension Canada.
The primary objective of the SIMPLE-AOBP study is to assess whether foregoing, or simplifying, specific elements of the AOBP procedure affects its accuracy towards the gold-standard mean awake ABPM. This study will employ a rigorous methodology (highly standardized measurements, identical settings and rest periods, randomization, blinded assessment of outcomes, averaged multiple BP measurements) to minimise measurement biases not related to the studies elements. The study will focus on three easily addressable elements: 1) the need the measure BP on a bare arm, 2) the requirement of supporting the arm at heart level and 3) the need to use a validated BP device. This trial will provide important pilot data to help design adequately powered large scale studies.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Standardized automated office BP measurements | Active comparator | Diagnostic Test: Mean awake ambulatory BP measurementsBP measured using a highly standardized procedure using a validated office-grade device on a bare arm supported at heart level. |
| Sleeved arm | Active comparator | Diagnostic Test: Mean awake ambulatory BP measurementsBP measured using a highly standardized procedure using a validated office-grade device over a standardized sleeve with the arm supported at heart level. |
| Arm not supported | Active comparator | Diagnostic Test: Mean awake ambulatory BP measurementsBP measured using a highly standardized procedure using a validated office-grade device on a bare arm resting vertically. |
| Non-validated device | Active comparator | Diagnostic Test: Mean awake ambulatory BP measurementsBP measured using a highly standardized procedure using a non-validated home device on a bare arm supported at heart level. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Adults ≥ 18 years old
Key exclusion criteria (5 listed)
- Upper arm size outside of cuff range of selected devices (<22 cm or >42 cm)
- Permanent atrial fibrillation
- Known severe aortic stenosis
- Ongoing pregnancy
- Inability or unwillingness to provide consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mean awake ambulatory BP measurementsResults from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol. | Diagnostic test | Arm not supported, Non-validated device, Sleeved arm, Standardized automated office BP measurements |
Primary outcome
Difference with mean awake ambulatory systolic BP
Time frame: at enrollment (time 0)
Difference between systolic BP measured in each study arm (average of 3 measurements) with the mean awake ambulatory systolic BP
1 secondary outcome
Difference with mean awake ambulatory diastolic BP
Time frame: at enrollment (time 0)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Feb 2025.
- Individual participant dataSharing planned: No. Data will not be shared (pilot study)
Related trials for Blood Pressure
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingPhase 4
Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions
Hematologic Test, Agranulocytosis
Not yet recruiting
Acute Effects of Mat Pilates on Blood Pressure Response to Mental Stress in Higher Education Teachers
Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mean awake ambulatory BP measurements in people with Blood Pressure, run by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Difference with mean awake ambulatory systolic BP (time frame: at enrollment (time 0)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2025.